Trial Results Show Benefit of Vitamin D for Reducing Disease Activity in Clinically Isolated Syndrome
March 21, 2025
March 21, 2025
NEW YORK, March 21 -- The National Multiple Sclerosis Society issued the following news:
* * *
Trial Results Show Benefit of Vitamin D for Reducing Disease Activity in Clinically Isolated Syndrome
Results from a clinical trial in France showed that disease activity was significantly reduced in people with clinically isolated syndrome (CIS, a single clinical episode where a person experiences symptoms typical for MS) treated with high-dose vitamin D versus i . . .
* * *
Trial Results Show Benefit of Vitamin D for Reducing Disease Activity in Clinically Isolated Syndrome
Results from a clinical trial in France showed that disease activity was significantly reduced in people with clinically isolated syndrome (CIS, a single clinical episode where a person experiences symptoms typical for MS) treated with high-dose vitamin D versus i . . .